Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01711658
Title TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. (TRYHARD)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Radiation Therapy Oncology Group
Indications

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

Cisplatin + Lapatinib + Radiotherapy

Cisplatin + Radiotherapy

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST